A new experimental cancer drug has been designated a breakthrough therapy for some Hodgkin’s lymphoma patients. Eboni Williams takes a look at today’s top health stories. Source
A new experimental cancer drug has been designated a breakthrough therapy for some Hodgkin’s lymphoma patients. Eboni Williams takes a look at today’s top health stories. Source